ArticleTheranostics2020

Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer.

Bi Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.